The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
The typical dosage is 0.25 mg subcutaneously every 20 minutes to three hours. The drug is discontinued if the maternal heart rate exceeds 120 beats/min. Terbutaline is contraindicated if the ...
Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...